Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-08BCAX144Cohlhepp Ryan plan to sell securities of Bicara Therapeutics Inc. under Form 144MEDIUM
Cohlhepp Ryan filed Form 144 to notify SEC of plan to sell 17500 units of Bicara Therapeutics Inc. securities around 2026-09-08, with aggregate market value of $396,200.00. The total outstanding units is 66172934.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in past 3...
Small CapBiotechnology
2026-09-08BCAX144Hyep Ivan plan to sell securities of Bicara Therapeutics Inc. under Form 144MEDIUM
Hyep Ivan filed Form 144 to notify SEC of plan to sell 12500 units of Bicara Therapeutics Inc. securities around 2026-09-08, with aggregate market value of $283,000.00. The total outstanding units is 66172934.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past 3 mon...
Small CapBiotechnology
2026-09-08IPSC144Russotti Gregory plan to sell securities of Century Therapeutics, Inc. under Form 144MEDIUM
Russotti Gregory filed Form 144 to notify SEC of plan to sell 534 units of Century Therapeutics, Inc. securities around 2026-09-08, with aggregate market value of $1,094.43. The total outstanding units is 181075321.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past...
Small CapBiotechnology
2026-09-08CTNM144CARMINE STENGONE plan to sell securities of Contineum Therapeutics, Inc. under Form 144MEDIUM
CARMINE STENGONE filed Form 144 to notify SEC of plan to sell 2500 units of Contineum Therapeutics, Inc. securities around 2026-09-08, with aggregate market value of $41,750.00. The total outstanding units is 32958632.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in p...
Small CapBiotechnology
2026-09-08CGEM144JENNIFER MICHAELSON plan to sell securities of CULLINAN THERAPEUTICS, INC. under Form 144MEDIUM
JENNIFER MICHAELSON filed Form 144 to notify SEC of plan to sell 8000 units of CULLINAN THERAPEUTICS, INC. securities around 2026-09-08, with aggregate market value of $176,720.00. The total outstanding units is 64354694.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions i...
Small CapBiotechnology